Australian company EPOC Enviro's Surface-Active Foam Fractionation (SAFF) technology has commenced a full-scale PFAS remediation trial at an Australian wastewater ...
Kelyniam Global (OTC: KLYG), a leader in custom cranial implants, today reported its financial results for the first quarter ...
Falun Municipality has announced its intention to award Terranor AB, a subsidiary of the Terranor Group, a public tender for operation and maintenance of outdoor environments in Area A of Falun Munici ...
Canatu Plc Inside information 11 May 2026 at 09:00 a.m. EEST Inside information: Canatu announces a leadership transition - Dr. Maximilian Slawinski appointed as CEO and successor to Juha Kokkonen Can ...
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced a col ...
Annexin Pharmaceuticals AB today announces that the company has received an approval for a clinical trial with the drug candidate ANXV by the German Medicines Agency Bundesinstitut für Arzneimittel un ...
FDA's updated Enforcement Guidance issued on May 8 marks an important step toward improved regulatory oversight and continued maturation of the U.S. nicotine product market. The updated guidance is ex ...
A joint effort from Applied, One Call, and Verisk brings a digitally enabled insurance product to market through simplified connectivity for insuredsLONDON, May 11, 2026 (GLOBE NEWSWIRE) -- As UK insu ...
VANCOUVER, BC / ACCESS Newswire / May 11, 2026 / Ameriwest Critical Metals Inc. (CSE:AWCM)(OTC:AWLIF)(FSE:5HV) ("Ameriwest" ...
VANCOUVER, BC, May 11, 2026 /CNW/ - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (TSXV: SNM) (Nasdaq First North: SNM) announces that the process to change the Company's primary listing from ...
Snark BidCo AB[1] (the "Offeror"), a company controlled by Altor Fund V (No.1) AB and Altor Fund V (No.2) AB, today announced a public takeover offer to the shareholders of Sleep Cycle AB (publ) ("Sle ...
Diamyd Medical today announces that the initial phase of the strategic review, initiated following the discontinuation of the Phase 3 DIAGNODE-3 trial, has been completed. Strategic review update The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results